Skip to main content

Prime Medicine, Inc 8-K, filed Nov 10, 2026

Prime Medicine, Inc. (PRME)

8-K 2026-11-10 For: 2026-11-10
View Original
Added on November 10, 2026

About this 8-K

Prime Medicine, Inc filed this 8-K on November 10, 2026.

Prime Medicine estimated cash, cash equivalents and short-term investments of approximately $61.2 million as of September 30, 2026, excluding approximately $13.7 million of restricted cash; the unaudited figures remained subject to quarter-end closing adjustments. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits